We found that the highest scoring tumor-associated signaling was the ErbB signaling pathway, and triptonodiol may act by directly targeting PKC, PAK, and GSK3B, which is consistent with the results of the PPI network. The gene discussed is PRRT2; the disease is neoplasm.